🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed weight-reducing properties. Followers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Experts Express Worries

Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to users injecting substances of unknown origin.

Several experts said the demand for the experimental drug could be connected to the rising price of licensed slimming products such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to fines, prosecution or prison.

Service Reaction and Content Removal

Based on the social media company, the platform has removed problematic material and banned associated hashtags and search suggestions. The organization said it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also discovered communities with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, filled with photos of weight loss, positive testimonials and step-by-step guides for preparing or administering at home.

After moments of joining one group, a seller posted WhatsApp details, where the majority of purchases take place. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, health issues or previous experience.

Item Details and Costs

Within these groups, posts display black plastic packages with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for Telegram stated it actively monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is sound, these online versions may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit injections are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has already encountered individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose users to potentially significant health risks”.